About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
GRACE
cancergrace.org
Podcast Series
Targeted Therapies in Lung Cancer 2023
ASCO® 2023
Lung Cancer OncTalk
Blood Cancer OncTalk
2022 Melanoma Video Library
OncTalk 2022
ASCO Lung Review 2022
ASCO and ESMO Lung Recap
2021 Targeted Therapies Patient Forum
COVID-19
Lung
Hematologic Oncology
Head and Neck
Brain
Palliative
Genitourinary
General
Breast
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
CheckMate 816: Combining Chemo and Opdivo in Stage 1B-3A NSCLC
By
GRACE
FEATURING
Jack West
,
Jarushka Naidoo
,
Gilberto Lopes
By
GRACE
FEATURING
Jack West
,
Jarushka Naidoo
,
Gilberto Lopes
537 views
September 6, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
20:25
Exelixis
Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…
Feat.
S. Ratnam
Featured Video
20:59
Exelixis
Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…
Feat.
S. Ratnam
ASCO Lung Review 2022
14:26
GRACE
The Need for Molecular Testing to Identify Targets in mNSCLC
Feat.
J. West,
J. Naidoo,
G. Lopes
12:38
GRACE
IO Alone vs. IO + Chemo for NSCLC Pts w/PD-L1≥50%
Feat.
J. West,
J. Naidoo,
G. Lopes
07:22
GRACE
Chemo/IO vs. IO vs. Chemo for KRAS-Mutated NSCLC
Feat.
J. West,
J. Naidoo,
G. Lopes
07:37
GRACE
Pembrolizumab/Ramucirumab vs. Standard 2L Treatment After Chemo and …
Feat.
J. West,
J. Naidoo,
G. Lopes
09:17
GRACE
Amivantamab/Lazertinib for EGFRm+ NSCLC Acquired Resistance
Feat.
J. West,
J. Naidoo,
G. Lopes
07:11
GRACE
EGFRm+ NSCLC: Should We Treat With Durvalumab?
Feat.
J. West,
J. Naidoo,
G. Lopes
05:29
GRACE
Patritumab Deruxtecan: Use in Previously Treated NSCLC Without Mutat…
Feat.
J. West,
J. Naidoo,
G. Lopes
04:28
GRACE
SKYSCRAPER-2 Trial: Anti-“TIGIT” IO + Chemo/IO for ES-SCLC
Feat.
J. West,
J. Naidoo,
G. Lopes
07:56
GRACE
CheckMate 816: Combining Chemo and Opdivo in Stage 1B-3A NSCLC
Feat.
J. West,
J. Naidoo,
G. Lopes
12:08
GRACE
Adagrasib for Previously Treated KRAS G12C+ NSCLC
Feat.
J. West,
J. Naidoo,
G. Lopes